Clinical trial
Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid…
NCT00004059 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004059 |
|---|---|
| Title | Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors |
| Official title | A Phase I Study of the Cyclin-Dependent Kinase (CDK)/Protein Kinase C (PKC) Inhibitor UCN-01 (NSC 638850) in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | 7-hydroxystaurosporine, fluorouracil |
| Start date | Jul 1, 1999 |
| Primary completion | Sep 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | May 8, 2003 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: